GlassScriptPhysician profile
Katherine E Kennedy
NPI 1316290893
$901.19
in general payments reported to CMS, 2019-2025
15 companies · $252 in 2025
The $252 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.90 · 2020: $53.42 · 2021: $147 · 2022: $202 · 2023: $153 · 2024: $67.41 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aap Implants INC | $180.32 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $131.48 | 2023 | Nuzyra |
| Astrazeneca Pharmaceuticals LP | $130.53 | 2025 | Airsupra |
| Orthofix Medical, INC. | $115.96 | 2019-2025 | Physio-Stim |
| Abbvie INC. | $54.90 | 2025 | |
| Advanced Oxygen Therapy INC. | $48.31 | 2021-2025 | Topical Oxygen Chamber For Extremities |
| Smith+Nephew, INC. | $47.26 | 2024 | Grafix Pl |
| Vertex Pharmaceuticals Incorporated | $34.80 | 2024-2025 | |
| Bioventus LLC | $30.50 | 2021-2022 | |
| Osteomed LLC | $30.20 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.50 | 2020-2021 | |
| Stryker Corporation | $21.83 | 2023 | Smart Toe |
| Organogenesis INC. | $18.99 | 2022 | |
| Medtronic, INC. | $13.96 | 2025 | Inceptiv |
| Merck Sharp & Dohme LLC | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Kennedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.